A study listed on ClinicalTrials.gov.

Recruiting now. Registry record last updated June 3, 2026.

Who can join: Adults 18+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The study runs about 12 months.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor Mayo ClinicDrug investigational drugClass OtherSites 1 USEnrollment target 150

What this study is for

Primary condition: Upper Endoscopy. Also studied in: GLP1-R-related Disease.

Full scientific study title: Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists.

Who can join

Age18 and upSexAny

Adults 18+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Patients undergoing elective upper endoscopy with gastroenterology team

Key exclusion criteria

Urgent or emergent procedure
Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
Upper GI barium study performed in past 24 hours.
Gastroparesis
Achalasia

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Minnesota1 site

Mayo Clinic in Rochester
Rochester, Minnesota
Krishnan Ramanujan, MD507-422-4898ramanujan.krishnan@mayo.edu

Follow this trial

We email you if NCT07006142 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: August 1, 2025. Expected completion: August 30, 2026. Last updated on ClinicalTrials.gov: June 3, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.